Pulse Biosciences (PLSE) Gross Profit (2021 - 2026)

Pulse Biosciences has reported Gross Profit for 4 years, with the latest figure at $161000.0 in Q2 2026.

• On a quarterly basis, Gross Profit changed N/A year-over-year to $161000.0 in Q2 2026; TTM through Jun 2026 was -$28000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$189000.0, changed N/A from the prior year.
• Gross Profit was $161000.0 for Q2 2026 at Pulse Biosciences, up from $4000.0 in the prior quarter.
• The five-year high for Gross Profit was $161000.0 in Q2 2026, with the low at -$8.4 million in Q3 2022.
• Average Gross Profit over 3 years is -$1.6 million, with a median of -$465000.0 recorded in 2022.
• The largest YoY upside for Gross Profit was 227.46% in 2022 against a maximum downside of 5390.2% in 2022.
• Over 3 years, Gross Profit stood at -$1.3 million in 2022, then soared by 100.31% to $4000.0 in 2025, then surged by 3925.0% to $161000.0 in 2026.
• The last three Gross Profit figures came in at $161000.0 (Q2 2026), $4000.0 (Q4 2025), and -$193000.0 (Q3 2025), per Business Quant data.